2
1
Schedule 2 to the Misuse of Drugs Act 19712 (which specifies the drugs which are subject to control under that Act) shall be amended as follows:
2
In paragraph 1(a) of Part I of that Schedule there shall be inserted—
a
after “Dihydrocodeinone O-carboxymethyloxime”, “Dihydroetorphine”; and
b
after “Racemorphan”, “Remifentanil.”.
3
In paragraph 1(a) of Part III of that Schedule, there shall be inserted—
a
after “Haloxazolam”, “4-Hydroxy-n-butyric acid”; and
b
after “N-Ethylamphetamine”, “Zolpidem”.
4
In paragraph 1(b) of Part III of that Schedule, there shall be inserted—
a
before “Atamestane”, “4-Androstene-3, 17-dione” and “5-Androstene-3, 17-diol”; and
b
after “Nandrolone”, “19-Nor-4-Androstene-3, 17-dione”; and “19-Nor-5-Androstene-3, 17-diol”.